Apoptosis and insulin resistance in liver and peripheral tissues of morbidly obese patients is associated with different stages of non-alcoholic fatty liver disease

Diabetologia

Volumn 54, Issue 7, 2011, Pages 1788-1798

  Ferreira, D M S ^a   Castro, R E ^a   MacHado, M V ^b,c   Evangelista, T ^b   Silvestre, A ^b   Costa, A ^b   Coutinho, J ^b   Carepa, F ^b   Cortez Pinto, H ^b,c   Rodrigues, C M P ^a  

^a UNIVERSITY OF LISBON   (Portugal)

^b HOSPITAL DE SANTA MARIA   (Portugal)

^c INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

Author keywords

Caspase 2; Cell death; Insulin resistance; JNK; Non alcoholic steatohepatitis; Obesity; Steatosis

Indexed keywords

CASPASE 2; CASPASE 3; INSULIN; INSULIN RECEPTOR SUBSTRATE; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; TYROSINE;

ADIPOSE TISSUE; ADULT; APOPTOSIS; ARTICLE; BARIATRIC SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DNA FRAGMENTATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN RESISTANCE; LIVER BIOPSY; MALE; MORBID OBESITY; MUSCLE TISSUE; NONALCOHOLIC FATTY LIVER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TISSUE SECTION;

ADULT; APOPTOSIS; FATTY LIVER; FEMALE; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; LIVER; MALE; MIDDLE AGED; MUSCLE, SKELETAL; OBESITY;

EID: 79959755613     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-011-2130-8     Document Type: Article

References (47)

1. E Vanni E Bugianesi A Kotronen S de Minicis H Yki-Jarvinen G Svegliati-Baroni 2010 From the metabolic syndrome to NAFLD or vice versa? Dig Liver Dis 42 320 330 20207596 10.1016/j.dld.2010.01.016 1:CAS:528: DC%2BC3cXotVejt78%3D
2. G Marchesini M Brizi G Bianchi, et al. 2001 Nonalcoholic fatty liver disease: a feature of the metabolic syndrome Diabetes 50 1844 1850 11473047 10.2337/diabetes.50.8.1844 1:CAS:528:DC%2BD3MXlslKmsr4%3D (Pubitemid 33641605)
3. AE Feldstein NW Werneburg A Canbay, et al. 2004 Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway Hepatology 40 185 194 15239102 10.1002/hep.20283 1:CAS:528:DC%2BD2cXmtlSgur0%3D (Pubitemid 38868937)
4. CM Kusminski S Shetty L Orci RH Unger PE Scherer 2009 Diabetes and apoptosis: lipotoxicity Apoptosis 14 1484 1495 19421860 10.1007/s10495-009-0352- 8 1:CAS:528:DC%2BD1MXhtlKjsrnJ
5. PS Ribeiro H Cortez-Pinto S Sola, et al. 2004 Hepatocyte apoptosis, expression of death receptors, and activation of NF-kappaB in the liver of nonalcoholic and alcoholic steatohepatitis patients Am J Gastroenterol 99 1708 1717 15330907 10.1111/j.1572-0241.2004.40009.x 1:CAS:528:DC%2BD2cXos1egtbo%3D (Pubitemid 39237497)
6. P Puri F Mirshahi O Cheung, et al. 2008 Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease Gastroenterology 134 568 576 18082745 10.1053/j.gastro.2007.10.039 1:CAS:528:DC%2BD1cXivFOjs7w%3D (Pubitemid 351173040)
7. A Gastaldelli A Natali R Vettor SG Corradini 2010 Insulin resistance, adipose depots and gut: interactions and pathological implications Dig Liver Dis 42 310 319 20194050 10.1016/j.dld.2010.01.013 1:CAS:528:DC%2BC3cXotVejt74%3D
8. A Gastaldelli K Cusi M Pettiti, et al. 2007 Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects Gastroenterology 133 496 506 17681171 10.1053/j.gastro.2007. 04.068 1:CAS:528:DC%2BD2sXhtVWqsr%2FO (Pubitemid 47187337)
9. GS Hotamisligil P Peraldi A Budavari R Ellis MF White BM Spiegelman 1996 IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance Science 271 665 668 8571133 10.1126/science.271.5249.665 1:CAS:528:DyaK28XptVyhtQ%3D%3D (Pubitemid 26052915)
10. CR Bruce DJ Dyck 2004 Cytokine regulation of skeletal muscle fatty acid metabolism: effect of interleukin-6 and tumor necrosis factor-alpha Am J Physiol Endocrinol Metab 287 E616 E621 15149950 10.1152/ajpendo.00150.2004 1:CAS:528:DC%2BD2cXptVyitLg%3D (Pubitemid 39237888)
11. F Ofei S Hurel J Newkirk M Sopwith R Taylor 1996 Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM Diabetes 45 881 885 8666137 10.2337/diabetes.45. 7.881 (Pubitemid 26225502)
12. J Ventre T Doebber M Wu, et al. 1997 Targeted disruption of the tumor necrosis factor-alpha gene: metabolic consequences in obese and nonobese mice Diabetes 46 1526 1531 9287059 10.2337/diabetes.46.9.1526 1:CAS:528: DyaK2sXlvFemsro%3D (Pubitemid 27369096)
13. S Schenk M Saberi JM Olefsky 2008 Insulin sensitivity: modulation by nutrients and inflammation J Clin Invest 118 2992 3002 18769626 10.1172/JCI34260 1:CAS:528:DC%2BD1cXhtV2isb%2FE
14. G Sabio M Das A Mora, et al. 2008 A stress signaling pathway in adipose tissue regulates hepatic insulin resistance Science 322 1539 1543 19056984 10.1126/science.1160794 1:CAS:528:DC%2BD1cXhsVGltb%2FM
15. G Tuncman J Hirosumi G Solinas L Chang M Karin GS Hotamisligil 2006 Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance Proc Natl Acad Sci USA 103 10741 10746 16818881 10.1073/pnas.0603509103 1:CAS:528:DC%2BD28XntFWmsbo%3D (Pubitemid 44078046)
16. G Sabio J Cavanagh-Kyros HJ Ko, et al. 2009 Prevention of steatosis by hepatic JNK1 Cell Metab 10 491 498 19945406 10.1016/j.cmet.2009.09.007 1:CAS:528:DC%2BC3cXks1Clsro%3D
17. R Belfort L Mandarino S Kashyap, et al. 2005 Dose-response effect of elevated plasma free fatty acid on insulin signaling Diabetes 54 1640 1648 15919784 10.2337/diabetes.54.6.1640 1:CAS:528:DC%2BD2MXltVaitr4%3D (Pubitemid 40770753)
18. E Bugianesi AJ McCullough G Marchesini 2005 Insulin resistance: a metabolic pathway to chronic liver disease Hepatology 42 987 1000 16250043 10.1002/hep.20920 1:CAS:528:DC%2BD2MXht1amtb3E (Pubitemid 43112663)
19. JF Acaso S Pardo JT Real, et al. 2003 Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism Diabetes Care 26 3320 3325 10.2337/diacare.26.12.3320 (Pubitemid 37466894)
20. DE Kleiner EM Brunt M van Natta, et al. 2005 Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 1313 1321 15915461 10.1002/hep.20701 (Pubitemid 40770284)
21. BA Neuschwander-Tetri SH Caldwell 2003 Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference Hepatology 37 1202 1219 12717402 10.1053/jhep.2003.50193 (Pubitemid 36538699)
22. RM Ramalho H Cortez-Pinto RE Castro, et al. 2006 Apoptosis and Bcl-2 expression in the livers of patients with steatohepatitis Eur J Gastroenterol Hepatol 18 21 29 16357615 10.1097/00042737-200601000-00005 1:CAS:528: DC%2BD2MXhtlahu73K (Pubitemid 43004877)
23. H Malhi GJ Gores 2008 Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease Semin Liver Dis 28 360 369 18956292 10.1055/s-0028-1091980 1:CAS:528:DC%2BD1cXhsVKju7fF
24. AE Feldstein A Canbay P Angulo, et al. 2003 Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis Gastroenterology 125 437 443 12891546 10.1016/S0016-5085(03)00907-7 (Pubitemid 36929425)
25. LJ Goodyear F Giorgino LA Sherman J Carey RJ Smith GL Dohm 1995 Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects J Clin Invest 95 2195 2204 7537758 10.1172/JCI117909 1:CAS:528:DyaK2MXltlWrtLg%3D
26. S Piro L Spadaro M Russello, et al. 2008 Molecular determinants of insulin resistance, cell apoptosis and lipid accumulation in non-alcoholic steatohepatitis Nutr Metab Cardiovasc Dis 18 545 552 18063353 10.1016/j.numecd.2007.08.002 1:CAS:528:DC%2BD1cXhsV2htL7J
27. P Dongiovanni L Valenti R Rametta, et al. 2010 Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease Gut 59 267 273 20176643 10.1136/gut.2009.190801 1:CAS:528:DC%2BC3cXjsFeqsb8%3D
28. G Sesti 2006 Pathophysiology of insulin resistance Best Pract Res Clin Endocrinol Metab 20 665 679 17161338 10.1016/j.beem.2006.09.007 1:CAS:528:DC%2BD28Xht12ksb%2FO (Pubitemid 44856489)
29. JF Tanti J Jager 2009 Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation Curr Opin Pharmacol 9 753 762 19683471 10.1016/j.coph.2009.07. 004 1:CAS:528:DC%2BD1MXhsVGqs7vJ
30. CM Troy SA Rabacchi Z Xu, et al. 2001 β-Amyloid-induced neuronal apoptosis requires c-Jun N-terminal kinase activation J Neurochem 77 157 164 11279271 10.1046/j.1471-4159.2001.t01-1-00218.x 1:CAS:528:DC%2BD3MXis1KltL8%3D (Pubitemid 32245089)
31. 2-terminal kinase activation and elevated proapoptotic Bax J Nutr 138 1866 1871 18806094 1:CAS:528:DC%2BD1cXht1Sgu7fK
32. H Malhi SF Bronk NW Werneburg GJ Gores 2006 Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis J Biol Chem 281 12093 12101 16505490 10.1074/jbc.M510660200 1:CAS:528:DC%2BD28Xjslensb0%3D (Pubitemid 43855473)
33. AE Feldstein GJ Gores 2005 Apoptosis in alcoholic and nonalcoholic steatohepatitis Front Biosci 10 3093 3099 15970563 10.2741/1765 1:CAS:528:DC%2BD2MXntFGit7c%3D (Pubitemid 40910547)
34. JM Schattenberg M Schuchmann 2009 Diabetes and apoptosis: liver Apoptosis 14 1459 1471 19544096 10.1007/s10495-009-0366-2 1:CAS:528:DC%2BD1MXhtlKjsrbM
35. H Vakifahmetoglu-Norberg B Zhivotovsky 2010 The unpredictable caspase-2: what can it do? Trends Cell Biol 20 150 159 20061149 10.1016/j.tcb.2009.12.006 1:CAS:528:DC%2BC3cXisFemu7w%3D
36. Y Zhang SS Padalecki AR Chaudhuri, et al. 2007 Caspase-2 deficiency enhances aging-related traits in mice Mech Ageing Dev 128 213 221 17188333 10.1016/j.mad.2006.11.030 1:CAS:528:DC%2BD2sXntleguw%3D%3D (Pubitemid 46109019)
37. W Jobgen WJ Fu H Gao, et al. 2009 High fat feeding and dietary L-arginine supplementation differentially regulate gene expression in rat white adipose tissue Amino Acids 37 187 198 19212806 10.1007/s00726-009-0246-7 1:CAS:528:DC%2BD1MXltlemtLs%3D
38. NJ Tsagarakis I Drygiannakis AG Batistakis G Kolios EA Kouroumalis 2011 Octreotide induces caspase activation and apoptosis in human hepatoma HepG2 cells World J Gastroenterol 17 313 321 21253389 10.3748/wjg.v17.i3.313 1:CAS:528:DC%2BC3MXhvFOls78%3D
39. V Furstova T Kopska RF James J Kovar 2008 Comparison of the effect of individual saturated and unsaturated fatty acids on cell growth and death induction in the human pancreatic beta-cell line NES2Y Life Sci 82 684 691 18272185 10.1016/j.lfs.2007.12.023
40. RA Defronzo 2009 Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus Diabetes 58 773 795 19336687 10.2337/db09-9028 1:CAS:528:DC%2BD1MXktleitbw%3D
41. E Bugianesi A Gastaldelli E Vanni, et al. 2005 Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms Diabetologia 48 634 642 15747110 10.1007/s00125-005-1682-x 1:CAS:528:DC%2BD2MXjtlGhs7w%3D (Pubitemid 40591217)
42. S Patel A Flyvbjerg M Kozakova, et al. 2008 Variation in the ADIPOQ gene promoter is associated with carotid intima media thickness independent of plasma adiponectin levels in healthy subjects Eur Heart J 29 386 393 18084018 10.1093/eurheartj/ehm526 1:CAS:528:DC%2BD1cXjt1Whu7o%3D (Pubitemid 351197748)
43. S Boura-Halfon Y Zick 2009 Phosphorylation of IRS proteins, insulin action, and insulin resistance Am J Physiol Endocrinol Metab 296 E581 E591 18728222 10.1152/ajpendo.90437.2008 1:CAS:528:DC%2BD1MXkvVyhsbY%3D
44. R Singh Y Wang Y Xiang KE Tanaka WA Gaarde MJ Czaja 2009 Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance Hepatology 49 87 96 19053047 10.1002/hep.22578 1:CAS:528: DC%2BD1MXhsFGlt7Y%3D
45. JM Schattenberg R Singh Y Wang, et al. 2006 JNK1 but not JNK2 promotes the development of steatohepatitis in mice Hepatology 43 163 172 16374858 10.1002/hep.20999 1:CAS:528:DC%2BD28Xpt1Snsg%3D%3D (Pubitemid 43733603)
46. M Braga AP Sinha Hikim S Datta, et al. 2008 Involvement of oxidative stress and caspase 2-mediated intrinsic pathway signaling in age-related increase in muscle cell apoptosis in mice Apoptosis 13 822 832 18461459 10.1007/s10495-008-0216-7 1:CAS:528:DC%2BD1cXlvFaisrk%3D
47. RJ Viana RM Ramalho AF Nunes CJ Steer CM Rodrigues 2010 Modulation of amyloid-beta peptide-induced toxicity through inhibition of JNK nuclear localization and caspase-2 activation J Alzheimers Dis 22 557 568 20847398 1:CAS:528:DC%2BC3cXhsVektLjN